New entrant at Celyad
Belgium-based Celyad has had a new CMO since April: Dr Charles Morris.
The medical oncologist provides leadership and development of strategies for all medical, regulatory and clinical activities. Before he started at the biotechnology company, he served in the same position of Radius Health and held leadership positions at PsiOxus Therapeutics, ImmunoGen Inc and Allos Therapeutics. Furthermore, he was VP of Worldwide Clinical Research at Cephalon, Inc and held several positions at AstraZeneca.
Morris holds a Bachelor of Medicine, Bachelor of Surgery and Bachelor of Medical Sciences in Clinical Pharmacology and Therapeutics degree from Sheffield University Medical School (UK). He is a member of the Royal College of Physicians of London.